Target intelligence / Profile preview

Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (MAN1A2)

Target
MAN1A2
Molecular classification
Enzyme, Glycosylase, Glycoside hydrolase family 47 (GH47)
01

Overview

Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (MAN1A2) is a Golgi enzyme vital for trimming alpha-1,2-linked mannose residues from N-glycans, producing structures required for proper glycoprotein maturation[1][2][5]. It belongs to the glycoside hydrolase family 47 and plays a central role in posttranslational protein modification and glycan quality control within the secretory pathway. Its function is implicated in diverse biological processes, including anti-inflammatory responses (where its expression can be downregulated by TNFα and restored by PPARγ agonists), viral pathogenesis (with increased expression during hepatitis B infection), and cellular adaptation to tissue injury[1][3]. Mutations or disruption of MAN1A2 lead to altered glycan profiles and are linked to rare congenital disorders of glycosylation. The enzyme is also of considerable interest in biotechnology, where manipulation of MAN1A2 (alongside MAN1A1 and MAN1B1) enables the production of recombinant proteins with defined high-mannose glycosylation patterns[3][1][5].

Other names
MAN1A2MAN1BAlpha-1,2-mannosidase IBProcessing alpha-1,2-mannosidase IBmannosyl-oligosaccharide 1,2-alpha-mannosidase IBMannosidase alpha class 1A member 2MA1A2_HUMAN
02

Mechanism of action

Modulation of glycoprotein maturation by altering N-glycan processing. Anti-inflammatory action via glycan remodeling (for PPARγ agonists).

03

Biological functions

N-glycan maturationGlycoprotein quality controlGolgi-mediated processing of N-glycansMannose residue trimmingProtein glycosylationInflammatory modulation
04

Disease associations

Congenital disorder of glycosylation, type InRafiq syndromeViral infection (notably hepatitis B virus)Acute lung injury responsePossible implication in other glycosylation-related diseases
05

Safety considerations

Disruption impacts glycoprotein processing, which could affect cell functionMutations cause congenital glycosylation disordersPotential off-target effects when modulating glycosylation pathways
06

Interacting drugs

PPARγ agonists (e.g., rosiglitazone modulates MAN1A2 expression in inflammation context)
07

Biomarkers

Elevated MAN1A2 expression in hepatitis B infection correlates with hepatitis B surface antigen levelsCirculating MAN1A2 transcripts (as circular RNAs) may indicate expression modulation

Beyond the preview

Go deeper on Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (MAN1A2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (MAN1A2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call